Nemonapride - Moligand™, ≥99%(HPLC) , Antagonist of D 2 receptor;Antagonist of D 3 receptor;Antagonist of D 4 receptor, CAS No.75272-39-8, Antagonist of D 2 receptor;Antagonist of D 3 receptor;Antagonist of D 4 receptor

CAS: 75272-39-8 Cat. No.: N287462 Formula: C21H26ClN3O2 Molecular Weight: 387.91 EC Number: 689-004-7
AVAILABLE TO ORDER
GRADE & PURITY Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥99%(HPLC)
Synonyms
(+/-)-cis-N-(1-Benzyl-2-methyl-3-pyrrolidinyl)-5-chloro-4-(methylamino)-o-anisamide|(+-)-cis-N-(1-Benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide|5-chloro-2-methoxy-4-methylamino-N-[(2R,3R)-2-methyl-1-(phenylmethyl)pyrrolidin-3-yl]benzamide|Emilace (TN)|(2R,3R)-nemonapride|(+)-nemonapride|Emilace; Emonapride;; YM09151; YM09151-2|N-((2R,3R)-1-Benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide|YM-09151|Emonapride|N-[(2R,3R)-1-benzyl-2-methylpyrrolidin-3-yl]-5-chloro-2-methoxy-4-(methylamino)benzamide'|Nemonapride [INN:JAN]|NEMONAPRIDE [WHO-DD]|(+-)-cis-N-(1-Benzyl-2-methyl-3-pyrrolidinyl)-5-chloro-4-(methylamino)-o-anisamide|[3H]nemonapride|Benzamide, 5-chloro-2-methoxy-4-(methylamino)-N-((2R,3R)-2-methyl-1-(phenylmethyl)-3-pyrrolidinyl)-, rel-|N-(2RS,3RS)-(1-Benzyl-2-methyl-3-pyrrolidinyl)-5-chloro-2-methoxy-4-methylaminobenzamide|YM-09151-2|Emilace|Nemonapride (JAN/INN)|N-(Cis-1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide|5-Chloro-2-methoxy-4-(methylamino)-N-[(2R,3R)-2-methyl-1-(phenylmethyl)-3-pyrrolidinyl]benzamide|NEMONAPRIDE [MART.]|BENZAMIDE, 5-CHLORO-2-METHOXY-4-(METHYLAMINO)-N-(2-METHYL-1- (PHENYLMETHYL)-3-PYRROLIDINYL)-, CIS-(+/-)-|NEMONAPRIDE [JAN]|nemonapride|YM 09151-2|NEMONAPRIDE [MI]
Storage
Room temperature
Shipped In
Normal
★
Size
Germany (EU)
USA*
Price
Qty
10mg
N287462-10mg
Made to order · 8–12 wks
€379.12
50mg
N287462-50mg
Made to order · 8–12 wks
€1,586.14
Enter a quantity for the sizes you want to add.

Specifications

Synonyms
(+/-)-cis-N-(1-Benzyl-2-methyl-3-pyrrolidinyl)-5-chloro-4-(methylamino)-o-anisamide | (+-)-cis-N-(1-Benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide | 5-chloro-2-methoxy-4-methylamino-N-[(2R,3R)-2-methyl-1-(phenylmethyl)pyrrolidin-3-yl]benzamide | Emilace (TN) | (2R,3R)-nemonapride | (+)-nemonapride | Emilace; Emo Show more
Specifications & Purity
Moligand™, ≥99%(HPLC)
Biochemical and Physiological Mechanisms
Highly potent dopamine D2-like receptor antagonist; selective over D1-like receptors (Kivalues are 0.1 and 740 nM for D2-like and D1-like receptors respectively). Also potent 5-HT1Areceptor agonist (IC50= 34 nM) and has affinity for sigma receptors.
Storage
Room temperature
Shipped In
Normal
Grade
Moligand™
Action Type
ANTAGONIST
Mechanism of action
Antagonist of D 2 receptor;Antagonist of D 3 receptor;Antagonist of D 4 receptor
Purity
≥99%(HPLC)
Names and Identifiers
SMILES
CC1C(CCN1CC2=CC=CC=C2)NC(=O)C3=CC(=C(C=C3OC)NC)Cl
IUPAC Name
N-[(2R,3R)-1-benzyl-2-methylpyrrolidin-3-yl]-5-chloro-2-methoxy-4-(methylamino)benzamide
InChIKey
KRVOJOCLBAAKSJ-RDTXWAMCSA-N
InChI
1S/C21H26ClN3O2/c1-14-18(9-10-25(14)13-15-7-5-4-6-8-15)24-21(26)16-11-17(22)19(23-2)12-20(16)27-3/h4-8,11-12,14,18,23H,9-10,13H2,1-3H3,(H,24,26)/t14-,18-/m1/s1
Isomeric SMILES
C[C@@H]1[C@@H](CCN1CC2=CC=CC=C2)NC(=O)C3=CC(=C(C=C3OC)NC)Cl
Alternate CAS
187139-87-3,75272-39-8
MeSH Entry Terms
cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide;emonapride;nemonapride;nemonapride, (cis)-isomer;YM 09151-2;YM 09151-M;YM-09151-2
Molecular Weight
387.91
Reaxys
8349928
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=8349928&ln=

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassBenzenoids
ClassBenzene and substituted derivatives
SubclassBenzoic acids and derivatives
Intermediate Tree Nodes Aminobenzoic acids and derivatives
Direct ParentAminobenzamides
Alternative Parents 3-halobenzoic acids and derivatives  Aminophenyl ethers  Benzamides  Methoxyanilines  Anisoles  Benzoyl derivatives  Benzylamines  Phenylmethylamines  Methoxybenzenes  Phenoxy compounds  Phenylalkylamines  Chlorobenzenes  Alkyl aryl ethers  Secondary alkylarylamines  N-alkylpyrrolidines  Aryl chlorides  Secondary carboxylic acid amides  Amino acids and derivatives  Trialkylamines  Azacyclic compounds  Hydrocarbon derivatives  Organic oxides  Organochlorides  Organopnictogen compounds  
Molecular FrameworkAromatic heteromonocyclic compounds
Substituents 3-halobenzoic acid or derivatives - Halobenzoic acid or derivatives - Aminobenzamide - Aminophenyl ether - Methoxyaniline - Benzamide - Phenylmethylamine - Phenol ether - Benzylamine - Phenoxy compound - Benzoyl - Aniline or substituted anilines - Phenylalkylamine - Anisole - Methoxybenzene - Chlorobenzene - Aralkylamine - Secondary aliphatic/aromatic amine - Alkyl aryl ether - Halobenzene - N-alkylpyrrolidine - Aryl chloride - Aryl halide - Pyrrolidine - Amino acid or derivatives - Tertiary aliphatic amine - Carboxamide group - Tertiary amine - Secondary carboxylic acid amide - Ether - Carboxylic acid derivative - Organoheterocyclic compound - Azacycle - Secondary amine - Organopnictogen compound - Organic oxygen compound - Organic nitrogen compound - Amine - Hydrocarbon derivative - Organic oxide - Organohalogen compound - Organochloride - Organonitrogen compound - Organooxygen compound - Aromatic heteromonocyclic compound
DescriptionThis compound belongs to the class of organic compounds known as aminobenzamides. These are organic compounds containing a benzamide moiety with an amine group attached to the benzene ring.
External Descriptors N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide
3D Structure
Interactive Chemical Structure Model





Associated Targets(Human)
DRD2 Tclin D(2) dopamine receptor (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
DRD4 Tchem D(4) dopamine receptor (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
TMEM97 Tchem Sigma intracellular receptor 2 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
DRD3 Tclin D(3) dopamine receptor (3 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
Certificates (CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Chemical and Physical Properties
SolubilitySolvent:ethanol, Max Conc. mg/mL: 7.76, Max Conc. mM: 20; Solvent:DMSO, Max Conc. mg/mL: 9.7, Max Conc. mM: 25
Molecular Weight387.9
XLogP33.900
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count6
Exact Mass387.171 Da
Monoisotopic Mass387.171 Da
Topological Polar Surface Area53.600 Ų
Heavy Atom Count27
Formal Charge0
Complexity486.000
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Safety and Hazards(GHS)
x_symbol
x_signal_word
Warning
x_hazard_statements

H302:Harmful if swallowed

x_precautionary_statements

P264:Wash hands [and …] thoroughly after handling.

P270:Do not eat, drink or smoke when using this product.

P330:Rinse mouth.

P301+P312:IF SWALLOWED: call a POISON CENTER/doctor/... IF you feel unwell.

P501:Dispose of contents/container to an approved waste disposal plant.

x_reaxy_rn
8349928
x_reaxys_rn_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=8349928&ln=
Solution Calculators
Reviews

Customer Reviews

Application Protocols

Per the instruction to include only product-data–supported protocols: no tested applications, recommended dilutions, or validated assay formats are provided in the Product Data for this item.

  • Tested applications: Not specified for this item; refer to CoA/Spec Sheet.
  • Recommended working concentrations: Not specified for this item; refer to CoA/Spec Sheet.
  • Positive controls/standards: Not specified for this item; refer to CoA/Spec Sheet.

Users should develop and validate protocols suited to their assay systems (binding or functional readouts) and confirm compound handling (solubility, stability) under those conditions.

Biological Roles

Biochemical context (literature, general):

  • Nemonapride is widely cited as a high-affinity ligand for dopamine D2-like receptors and is used in receptor pharmacology to interrogate dopaminergic signaling. It has also been employed as a reference compound in binding studies with labeled tracers (e.g., [3H]-nemonapride) to quantify receptor density (Bmax) and affinity (KD). These roles are research-oriented and non-clinical.
  • Mechanistic role: functions as an antagonist in GPCR-mediated pathways, enabling dissection of basal vs agonist-stimulated signaling in heterologous expression systems and native tissues.
  • Systems biology applications: assists in mapping receptor distribution, receptor reserve, and downstream pathway coupling (Gαi/o inhibition of adenylyl cyclase, β‑arrestin recruitment) in cell lines and membrane preparations.

Important caveats:

  • The Product Data for this catalog item do not specify target specificity, potency, or selectivity. Any use in biological experiments should begin with confirmation of identity, purity, and activity using internal controls.
  • Experimental variables (membrane composition, receptor expression, assay temperature, and DMSO content) can strongly influence apparent pharmacology; standardize conditions and include appropriate reference ligands for comparison.

No medical or therapeutic claims are made. This material is intended strictly for laboratory research use.

Buffer Applications

This compound is not a buffering agent and is not used to establish pH control directly.

Practical notes for assay buffers (general guidance for ligand studies):

  • Vehicle: deliver from concentrated DMSO stocks; maintain final DMSO at ≤0.5–1% v/v to minimize vehicle effects on cells and receptors.
  • Typical binding assay buffers: 50 mM Tris-HCl, pH 7.4, with 120 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2; include 0.1% BSA to reduce non-specific binding (optimize per system).
  • Functional assays: HEPES-buffered saline (10–20 mM HEPES, pH 7.3–7.4) or assay‑specific media (e.g., HBSS) with low serum/protein as needed to control ligand binding kinetics.

Item-specific buffer compatibility, pKa, and solubility are Not specified for this item; refer to CoA/Spec Sheet and validate experimentally in your assay matrix.

Green Alternatives

While nemonapride itself is the active research ligand (no greener “substitute” for the analyte), greener choices can be made in solvent use and assay workflow.

Greener solvent considerations (general):

  • Prefer aqueous buffers with minimal DMSO (≤0.5–1% v/v) in final assay media.
  • For organic stock preparation, DMSO is commonly used; consider glycerol or propylene carbonate as alternative high‑boiling, lower‑volatility co‑solvents if compatible with your assay.
  • Avoid chlorinated solvents for any cleanup or workup associated with analytical method development; use ethanol or isopropanol where feasible.

Comparison (general, not item-specific specifications):

  • DMSO vs propylene carbonate
    • Pros (DMSO): very high solubilizing power; complete water miscibility; established toxicology and assay baselines.
    • Pros (propylene carbonate): lower toxicity profile and volatility; may reduce plasticizer extraction.
    • Tradeoffs: viscosity and assay compatibility must be validated case by case.
  • Methanol/Acetonitrile in analytics
    • Where possible, increase aqueous content, use ethanol as a greener modifier, and employ shorter columns/shallower gradients to reduce solvent consumption.

Operational sustainability:

  • Use microplate formats to minimize reagent volumes.
  • Aliquot compound stocks to reduce waste from stability losses.
  • Implement solvent recycling for HPLC mobile phases where compliant with analytical requirements.
Pharmaceutical Uses

No clinical or therapeutic uses are claimed or supported for this catalog item. For research use only.

Relevant non-clinical/formulation contexts (general):

  • Reference standard: can serve as a reference compound during analytical method development (e.g., LC–MS/MS) for dopamine-receptor–targeted program support, provided identity/purity are verified from the CoA.
  • In vitro pharmacology: benchmarking antagonist responses across engineered cell lines or tissue membranes in discovery screening.
  • Stability-indicating methods: useful as a challenge compound when developing stability-indicating chromatographic methods for related scaffolds.

Regulatory note: No pharmacopeial monograph or compendial status is provided in the Product Data. Any use outside basic research (e.g., GLP/GMP settings) requires independent qualification of identity, purity, and stability to program-specific standards.

Physical Properties
  • Appearance (product data): Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point, boiling point, density, refractive index: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility (item-specific): Not specified for this item; refer to CoA/Spec Sheet.

General/literature guidance for handling small-molecule GPCR ligands similar to nemonapride (informational, not item-specific specifications):

  • Physical state: typically solid at ambient conditions for the free base or salt forms used in screening collections.
  • Solubility trends: often readily soluble in aprotic polar organics (DMSO, DMF) and moderately to sparingly soluble in alcohols (MeOH, EtOH). Aqueous solubility depends strongly on ionization state (free base vs. hydrochloride or other salt).
  • pKa/logP (literature expectations for benzamide amine ligands): basic pKa for the aliphatic amine side chain commonly ~8–10; logP typically in the 2–4 range, supporting membrane permeability in receptor assays. Specific values for this item are not assigned here.

Practical tips (general):

  • Prepare concentrated DMSO stocks (e.g., 10–50 mM), then dilute into assay buffer keeping final DMSO ≤0.5–1% v/v to minimize vehicle effects.
  • If salt form is unknown, perform a small-scale solubility screen (water, PBS pH 7.4, DMSO, MeOH) before large preparations.
  • Verify hygroscopicity and polymorphic behavior, if any, via CoA before quantitative solution preparation.
Quality and Grades
  • Item-specific grade: Moligand™ (per Product Data)

What Moligand™ implies (general description of grade intent):

  • Moligand™ denotes a small‑molecule ligand quality suitable for discovery screening, target engagement studies, and pharmacology research. Emphasis is placed on identity verification and suitability for bioassay use rather than chromatographic solvent performance.
  • Typical controls for a ligand-grade material (general): structure confirmation (e.g., NMR/LC–MS), purity suitable for screening assays, and guidance for solution preparation in DMSO or aqueous co‑solvent systems. Exact purity percentage, counterion content, residual solvent, and water/peroxide/metal limits are Not specified for this item; refer to CoA/Spec Sheet.

How to use this grade effectively:

  • Recommended for receptor binding/functional assays, SAR benchmarking, and as a reference standard in analytical development.
  • If using in quantitative studies (KD/IC50 determination), confirm batch-specific purity and counterion/salt form from the CoA to ensure accurate molarity calculations.
  • For light-, heat-, or moisture‑sensitive ligands, minimize exposure during weighing and solution prep; if sensitivity is unknown, adopt protective handling (amber vials, desiccation) until verified.

Regulatory note:

  • This product is provided strictly for research use only; it is not intended for human or veterinary use, diagnostic procedures, or clinical applications.
Reaction and Applications

This product is primarily a research ligand rather than a synthetic reagent. No manufacturer application notes were provided beyond research use. The following focuses on research assay applications (general, literature-based) relevant to nemonapride-like compounds:

  • Receptor pharmacology
    • Competitive binding assays against labeled ligands (e.g., radioligands such as [3H]-labeled antagonists) to derive Ki/IC50 for dopamine D2-like receptors; item-specific target data are not provided here and should not be inferred.
    • Functional GPCR assays (G-protein or β‑arrestin biosensors) to assess antagonist behavior and probe receptor reserve.
  • Target engagement and profiling
    • Off-target screening across GPCR panels to build selectivity profiles; useful in SAR benchmarking.
  • Analytical use
    • Reference compound for LC–MS method development and retention time locking in complex matrices; purity and exact MW must be verified on the CoA before quantitative use.

Practical assay tips (general):

  • Prepare fresh DMSO stocks and avoid repeated freeze–thaw. Validate absence of adsorption to plastics by recovery checks at low nM–µM levels.
  • Use balanced salt buffers at near-physiological pH (7.2–7.4) and include BSA (0.1–0.5%) where non-specific binding is problematic.
  • Confirm ligand stability during assay windows via spot LC–MS or HPLC, especially at elevated temperatures or light exposure.

Note: No item-specific receptor potency/selectivity is provided in the Product Data; consult primary literature and the CoA for definitive guidance.

Reaction Conditions

Nemonapride is provided as a research ligand, not as a reagent for chemical synthesis; therefore, standard “reaction conditions” are generally not applicable.

For researchers conducting receptor assays (general, literature-based guidance rather than item specifications):

  • Binding assays: incubations typically at 22–30°C for 30–120 min in Tris or HEPES buffers (pH ~7.4), with membranes expressing receptors of interest. Include appropriate radioligand or fluorescent tracer and define non‑specific binding with an established high-affinity competitor.
  • Functional GPCR assays: exposure times 5–60 min depending on readout (cAMP, calcium flux, β‑arrestin), with careful control of DMSO (≤0.5–1% v/v) and temperature (ambient vs 37°C) as required by the biosensor system.
  • Data analysis: derive IC50 from concentration–response curves and convert to Ki with the Cheng–Prusoff equation using tracer KD determined under the same conditions.

These conditions are general literature practices and must be optimized per system. No item-specific kinetic or potency data are provided in the Product Data.

Safety and Handling

Safety data for this catalog item is limited in the provided Product Data. Always consult the SDS for authoritative guidance.

  • GHS classification, signal word, hazard statements, pictograms: Not specified for this item; refer to SDS.
  • Research use note (product data): For research use only.

General laboratory precautions for small-molecule receptor ligands (informational):

  • PPE: lab coat, safety glasses, and appropriate chemical-resistant gloves (e.g., nitrile). Handle powders in a fume hood to minimize inhalation exposure.
  • Avoid contact with skin/eyes and prevent aerosolization of fine particulates. Wash thoroughly after handling.
  • Pharmacologically active compounds can have potent biological effects at low doses; minimize exposure and implement good containment practices.
  • Incompatibilities: avoid strong oxidizers and strong acids/bases during storage unless the salt form and compatibility are known. Keep away from ignition sources when using organic solvents for dissolution.
  • First aid (general): in case of skin contact, wash with soap and water; for eye exposure, rinse cautiously with water for several minutes; if inhaled, move to fresh air; if ingested, rinse mouth. Seek medical attention if symptoms occur. Provide SDS to responders.
  • Spill response: cover solids with inert absorbent, avoid dust generation, collect mechanically; for solutions, absorb with appropriate material and dispose per institutional hazardous waste procedures.
Solvent Selection

Nemonapride, like many benzamide-type GPCR ligands, is commonly handled as concentrated DMSO stocks for bioassays. Item-specific solubility is not provided and should be confirmed on the CoA.

  • Polarity/miscibility (general expectations):
    • DMSO: excellent solvent for stock solutions; fully miscible with water for subsequent dilutions.
    • DMF, NMP: strong solvents if DMSO is contraindicated; consider toxicity and assay interference.
    • Alcohols (MeOH, EtOH): moderate solubility; can assist co‑solvent systems.
    • Aqueous buffers: solubility depends on ionization state and salt form; add last, after preparing a small DMSO concentrate.
  • Practical strategies:
    • Prepare 10–50 mM stocks in anhydrous DMSO; store aliquots to reduce freeze–thaw.
    • For aqueous work, add DMSO stock to vigorously stirred buffer to reach ≤0.5–1% DMSO v/v final.
    • If precipitation occurs on dilution, increase surfactant-free co‑solvent fraction slightly (e.g., 1–2% DMSO or ≤10% MeOH) or adjust pH to favor protonation of basic amines (literature guidance).
  • Comparison (general):
    • DMSO vs MeOH: DMSO gives higher solubility and stability but can affect some cell-based readouts above ~0.5–1%; MeOH has greater volatility and may extract plastics.
    • PBS vs HEPES: both are compatible vehicles; ensure buffering capacity at the intended assay pH and verify compound stability.

Note: Do not treat these as specifications. Confirm the actual solubility and salt form for this item from the CoA/Spec Sheet.

Storage and Reconstitution
  • Storage conditions (product data): Room temperature. Ship: Normal.
  • Appearance, stabilizer, and packaging: Not specified for this item; refer to CoA/Spec Sheet.

General guidance (informational, not item-specific specifications):

  • Solid storage: keep tightly capped in a dry, well‑ventilated area. Protect from prolonged light exposure. If hygroscopicity is unknown, store with desiccant.
  • Stock solutions: prepare concentrated solutions (e.g., 10–50 mM) in anhydrous DMSO. Filter through 0.2 µm PTFE only if particulate matter is observed and the compound is known to be stable.
  • Aliquoting: dispense small single‑use aliquots to avoid repeated freeze–thaw. If frozen, store at −20 to −80°C in amber vials; record preparation date and solvent.
  • Thawing and use: equilibrate to room temperature before opening to prevent moisture condensation. Mix gently; inspect for precipitation or discoloration prior to use.

Critical note: The exact reconstitution solvent, concentration limits, and solution stability for this item are Not specified for this item; refer to CoA/Spec Sheet. Validate stability in your intended matrix (buffer/media) before committing to large experiments.

Structure and Identity

Brief overview: Nemonapride is a small-molecule research ligand supplied in Aladdin’s Moligand™ grade, widely used in receptor pharmacology and binding assays.

  • Item-specific identifiers (from Product Data)
    • CAS: 75272-39-8
    • CID: 156333
    • InChIKey: 187937 (as provided)
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Structural features (literature, general)
    • Structural class: substituted benzamide–type dopamine receptor ligand (antagonist profile reported in literature).
    • Typical functional groups: amide (benzamide core); aryl substituents; aliphatic amine side chain (literature).
    • 2D description (literature): an aromatic benzamide ring bearing electron‑donating/withdrawing substituents, linked via the amide to a tertiary/secondary amine–containing aliphatic tether that engages GPCR orthosteric sites.
  • Stereochemistry (literature): some reports discuss enantiomeric preference in receptor binding for related scaffolds; item-specific stereochemical specification is not provided here.

Note: Exact structural string identifiers (SMILES/InChI) and confirmed formula/MW for this catalog item are not specified above and should be verified on the item’s CoA/Specification Sheet before use in regulated workflows.

Synthetic Utility

This product is supplied as a finished small-molecule ligand and is not typically employed as a general synthetic building block.

Potential roles in a synthetic/analytical context (general):

  • Reference in SAR: nemonapride-like benzamide antagonists can act as benchmarks to gauge the effect of structural modifications (ring substituents, amide/linker variations) on GPCR affinity and selectivity.
  • Analytical control: a convenient standard for validating extraction recovery, matrix effects, and ionization efficiency in LC–MS workflows for dopamine receptor ligand panels.

If derivatization is desired for probe development (general literature considerations):

  • Amide nitrogen or pendant amine functionalities on related scaffolds can be leveraged for coupling to fluorophores/affinity tags via NHS esters or isothiocyanates; however, site modification may markedly alter receptor affinity—re-validate activity post-derivatization.

Note: No item-specific functional-group map, salt form, or reactivity profile is provided in the Product Data. Consult the CoA/Spec Sheet for structural details before planning any chemical modification.

Target Specificity

Only product-data–verified target attributes may be listed here. For this item, the Product Data do not specify any validated targets, affinity values, or selectivity profiles.

  • Verified targets: Not specified for this item; refer to CoA/Spec Sheet.
  • Species reactivity or panel coverage: Not specified for this item; refer to CoA/Spec Sheet.

Note: Although nemonapride is discussed in literature as a dopamine receptor ligand, no item-specific target testing data are provided here. Users should generate or consult their own validation data under their assay conditions.

Frequently Asked Questions

What is the purity of this product, and how is it determined?
This product is supplied at ≥99% purity, determined by HPLC. Lot-specific values are stated on the Certificate of Analysis.
What is Moligand??
Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.
How should this product be stored?
Store at room temperature.
How is this product shipped?
This product ships under standard ambient conditions. No temperature-controlled packaging is required.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 75272-39-8, the molecular formula is C21H26ClN3O2, and the molecular weight is 387.91 g/mol. InChIKey KRVOJOCLBAAKSJ-RDTXWAMCSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.